GO
Loading...

Market Outlook

More

  • Why Long Herbalife?     Thursday, 10 Jan 2013 | 5:30 PM ET

    Sahm Adrangi, Kerrisdale Capital Management, explains why he took a long position on Herbalife when the stock was trading at $26.

  • Herbalife 'Poised to Bounce Back': Adrangi     Thursday, 10 Jan 2013 | 5:30 PM ET

    Herbalife's annual growth rate makes the stock attractive at its current level, Kerrisdale Capital Management Founder Sahm Adrangi says.

  • What a Hard Landing in China Means     Thursday, 10 Jan 2013 | 5:15 PM ET

    Certain sectors would be hit harder than others in the event of a sharp downturn in China this year, Societe Generale's Stephen Gallagher says.

  • China Hard Landing Risks     Thursday, 10 Jan 2013 | 5:15 PM ET

    China reported stronger-than-expected exports. Stephen Gallagher, Societe Generale, discusses whether there are hidden risks in its market, and what a hard landing would mean for the global economy.

  • US Equities Aren't Dead: Pro     Thursday, 10 Jan 2013 | 5:10 PM ET

    Scott Redler, Chief Strategic Officer, T3live.com says U.S. equity markets have started 2013 on the right note. He adds that the S&P 500 could reach 1,500 pretty quickly if it manages to close above 1,474.

  • Tomorrow in :30     Thursday, 10 Jan 2013 | 4:50 PM ET

    All eyes will be on the markets and earnings tomorrow, with Eric Marshall, Hodges Capital Management; Sameer Samana, Wells Fargo Advisors; and Michael James, Wedbush Securities.

  • Is the Rally Back On?     Thursday, 10 Jan 2013 | 4:00 PM ET

    The S&P closed at its highest levels in five years once again, with John Spallanzani, GFI Group; Ben Pace, Global Investment Solutions-Americas; Stephen Wood, Russell Investments; and Kenny Polcari, O'Neil Securities.

  • CNBC's Sharon Epperson discusses the day's activity in the commodities markets and looks at where oil and precious metals are likely headed tomorrow.

  • All Major Averages Higher for Week     Thursday, 10 Jan 2013 | 3:00 PM ET

    Insight on the market trading day, with Gordon Charlop, Rosenblatt Securities; Lee Munson, Portfolio Asset Management; and Stephen Wood, Russell Investments.

  • As Goes January, So Goes the Year?     Thursday, 10 Jan 2013 | 2:00 PM ET

    Craig Hodges, The Hodges Fund & Hodges Small Cap Fund, and Mark Travis, Intrepid Capital Funds, discuss whether 2013 will be a good year for investors.

  • FMHR Final Trade     Thursday, 10 Jan 2013 | 12:58 PM ET

    The FMHR traders reveal their final trades.

  • European Markets Close Flat After ECB Decision     Thursday, 10 Jan 2013 | 11:30 AM ET

    CNBC's Simon Hobbs reports on all the market moving events in Europe today, as the ECB decided to keep its interest rates unchanged at 0.75 percent.

  • Thursday Market Roadmap     Thursday, 10 Jan 2013 | 9:00 AM ET

    The "Squawk on the Street" news team reports on today's market moving stories, including the pending nomination of Jack Lew as Treasury Secretary; lowered sales expectations for luxury retailer, Tiffany; and the pop is shares of Nokia.

  • 'Super Mario's' Market Predictions     Thursday, 10 Jan 2013 | 8:16 AM ET

    Mario Gabelli, GAMCO Investors chairman, CEO & CIO, reveals his top stock plays for 2013, and weighs in on the outlook on the U.S. economy and "payroll shock" hitting workers' paychecks.

  • Roger Altman, Evercore Partners chairman & founder, shares his thoughts on the upcoming battle in Congress on the debt ceiling debate, referring to it as an "epic fight."

  • Five Major Investment Themes For 2013     Thursday, 10 Jan 2013 | 7:15 AM ET

    Jason Trennert, Strategas Research Partners, discusses the five investment themes investors need to heed in the coming year, including buying on big dips and a drop in earnings on the S&P 500.

  • Trader Buzz Before the Bell     Thursday, 10 Jan 2013 | 6:38 AM ET

    A look at what traders are watching ahead of the market's open, with Bob Iaccino, Topstep Trader.

  • No Huddle Offense: Alcoa's 4th Quarter     Wednesday, 9 Jan 2013 | 6:58 PM ET

    Mad Money host Jim Cramer shares his final thoughts of the day.

  • Am I Diversified? Cramer's Call!     Wednesday, 9 Jan 2013 | 6:45 PM ET

    Mad Money host Jim Cramer speaks to viewers about whether their top five holdings are diversified enough.

  • Acorda Therapeutics CEO Dr. Ron Cohen discusses the phase 2 studies happening on its mobility improvement drug Ampyra, and what's next for the company.